15 reports of this reaction
1.6% of all CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE reports
#11 most reported adverse reaction
DEATH is the #11 most commonly reported adverse reaction for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, manufactured by Actavis Pharma, Inc.. There are 15 FDA adverse event reports linking CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE to DEATH. This represents approximately 1.6% of all 933 adverse event reports for this drug.
Patients taking CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is a less commonly reported adverse event for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, but still significant enough to appear in the safety profile.
In addition to death, the following adverse reactions have been reported for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 15 FDA reports for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 1.6% of all adverse event reports for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, making it a notable side effect.
If you experience death while taking CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.